CRYOPORT, INC. Capital Leases, Income Statement, Interest Expense
CRYOPORT, INC. (CYRX) reported Capital Leases, Income Statement, Interest Expense of $4.18 thousand for the 3-month period ending 2019-03-31, per its 10-Q filed 2019-05-09.
Discontinued › Expense Statement › Interest Expense
us-gaap:CapitalLeasesIncomeStatementInterestExpense · last filed 2020-03-10
- CRYOPORT, INC. capital leases, income statement, interest expense for the quarter ending 2019-03-31 was $4.18K.
- CRYOPORT, INC. capital leases, income statement, interest expense for fiscal 2018 was $4.18K.
| Period end | Capital Leases, Income Statement, Interest Expense 3 month | Capital Leases, Income Statement, Interest Expense 12 month |
|---|---|---|
| 2019-03-31 | $4.18K 10-Q · filed 2019-05-09 | |
| 2018-12-31 | $4.18K 10-K · filed 2020-03-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Theravance Biopharma, Inc. (TBPH) | $0.885B | 16.40 | |
| RIGEL PHARMACEUTICALS INC (RIGL) | United States | $0.893B | 2.25 |
| Apnimed, Inc. (APMD) | United States | $0.899B | |
| ARDELYX, INC. (ARDX) | United States | $0.857B | -22.86 |
| Avalo Therapeutics, Inc. (AVTX) | United States | $0.842B | -9.74 |
| Immix Biopharma, Inc. (IMMX) | United States | $0.837B | -18.44 |
| Obsidian Therapeutics, Inc. (OBX) | United States | $0.829B | |
| Jade Biosciences, Inc. (JBIO) | United States | $0.936B | -9.21 |
| LEXICON PHARMACEUTICALS, INC. (LXRX) | United States | $0.823B | -17.48 |
| GYRE THERAPEUTICS, INC. (GYRE) | United States | $0.818B | -24.71 |